Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Diagnostic Accuracy of Combined Perfusion Index, Internal Jugular Vein Collapsibility Index and Cardiac Index in Predicting Post-Spinal Hypotension During Elective Cesarean Section

12 novembre 2026 mis à jour par: Nevine Mostafa Soliman, Menoufia University

Diagnostic Accuracy of Combined Perfusion Index, Internal Jugular Vein Collapsibility Index and Cardiac Index in Predicting Post-Spinal Hypotension During Elective Cesarean Section: A Prospective Randomized Study

compare Perfusion Index with Internal Jugular Vein Collapsibility Index (IJVCI) as a predictor for post-spinal hypotension in parturient undergoing elective caesarean section.

Aperçu de l'étude

Description détaillée

  • Pre-anesthetic evaluation (History-Investigation - Examination) the day before surgery.
  • NPO: 8 hours for solids, 2 hours for clear fluids.
  • Pre-medication: Ranitidine 50 mg IV + Metoclopramide 10 mg IV, 30 minutes before anesthesia.
  • 18-G IV cannula in the non-dominant forearm.
  • Standard monitoring in the operating room: pulse oximetry (SpO2), NIBP, and ECG.
  • Baseline measurements (HR, SBP, DBP, MAP, SpO2, PI, CI, IJVCI) recorded in the supine position with 15 degree left lateral tilt.
  • All indicators will be measured in a single group before spinal anesthesia and comparisons will be made for the most sensitive maneuver in prediction of post spinal hypotension.
  • Cardiac Index (CI) will be measured using cardiometry before spinal anesthesia.
  • Perfusion Index (PI) is measured (Three consecutive readings are recorded at 1-minute intervals, will be repeated with another reading after delivery of baby).• The cut-off applied is: -
  • 3.5 or less (low risk for hypotension)
  • Greater than 3.5 (high risk for hypotension)
  • Internal Jugular Vein Collapsibility Index will be measured by Ultrasonographic assessment and is performed by using a 6-10 MHz linear ultrasound probe. (The patient is placed supine with 15 degree left lateral tilt, The probe is positioned horizontally at the right side of the neck at the level of the middle thyroid cartilage, obtaining a transverse view of the right IJV. M-mode imaging during both spontaneous and deep breathing).
  • Anteroposterior diameters of the IJV were estimated during the respiratory cycle. The IJV collapsibility index (IJVCI) was estimated via the following equation: Maximum diameter - lowest diameter/maximum diameter) 100% .
  • The mean of three consecutive measurements is recorded for each breathing mode in quite respiratory cycle.
  • Images will be saved for offline analysis.
  • The cut-off applied is:

IJVCI < 35-38% → lower risk of post-spinal hypotension IJVCI ≥ 38-40% → higher likelihood of hypotension after spinal anesthesia in CS.

  • Spinal anesthesia with intrathecal drug regimen 10-12 mg of 0.5% hyperbaric bupivacaine plus 25 micrograms (mic) Fentanyl].
  • Co-loading with Ringer's lactate at 10ml/Kg will be administrated, along with spinal anesthesia placement .Data Collection

Baseline:

  1. Patient demographic data (age, ASA physical status, comorbidities, current medications, and BMI).
  2. Hemodynamics (Heart rate- Mean Arterial Blood Pressure - Systolic Blood Pressure -Oxygen Saturation) baseline reading before induction of spinal anesthesia.
  3. Preoperative IJVCI measurement by ultrasound imaging in supine position.
  4. Preoperative Perfusion Index reading.
  5. Preoperative Cardiac index reading.

Intraoperative:

  1. Hemodynamic parameters (SBP, DBP, MAP, HR, SpO2) are recorded: -

    • Every 1 minute for the first 10 minutes,
    • Every 3 minutes until delivery,
    • Every 5 minutes thereafter until end of surgery.
  2. Total phenylephrine dose in microgram & Total Ephedrine dose (mg) [if persistent hypotension].

  3. Total IV fluid volume (mL)

  4. Total Blood loss (mL)

  5. Total Urine output (mL)

  6. Time from spinal block to delivery (min)

  7. Total time of surgery.

  8. All adverse events (nausea, vomiting, hypotension, bradycardia, oxygen desaturation) are recorded throughout.

Definition of Outcomes All outcome definitions are pre-specified and uniformly applied across all patients: -

  • Post-spinal hypotension: A fall in systolic blood pressure (SBP) below 90 mmHg.
  • Episodes are recorded from the time of spinal injection until delivery of the baby.
  • Bradycardia: Heart rate below 50 beats per minute requiring pharmacological treatment with atropine 0.01 mg/kg IV.

Treatment of PSH

  • First-line: 200 mL Ringer's lactate rapid IV infusion.
  • If SBP remains below 90 mmHg phenylephrine 25-100 microgram if persistent hypotension gives Ephedrine 5-15 mg IV bolus.
  • Bradycardia (HR < 50 bpm): Atropine 0.01 mg/kg IV.
  • All vasopressor doses and additional fluid volumes administered are recorded.

Type d'étude

Observationnel

Inscription (Estimé)

50

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

      • Alexandria, Egypte
        • Recrutement
        • Menoufia University,Faculty of Medicine
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 40 ans (Adulte)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Femelle

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

Adults undergoing Elective Cesarean Section at Menoufia University Hospitals

La description

Inclusion Criteria:

  • Full-term pregnant women undergoing elective cesarean section under spinal anesthesia (gestational age >= 37 weeks), singleton pregnancy.

    • Age: 18-40 years.
    • ASA I, II.
    • BMI: 18.5-35 kg/m2.

Exclusion Criteria:

  • • Patient refusal or inability to provide informed consent.

    • Emergency cesarean section.
    • Known contraindications to spinal anesthesia (coagulopathy, local infection, elevated ICP).
    • Baseline hypotension (SBP < 100 mmHg) prior to spinal anesthesia.
    • Hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia).
    • Placenta previa or antepartum hemorrhage.
    • Multiple pregnancy or known fetal abnormality.
    • BMI > 35 kg/m2.
    • Pre-existing cardiovascular, cerebrovascular, or significant pulmonary disease.
    • Gestational diabetes or uncontrolled systemic disease.
    • Hemoglobin < 8 g/dL or known haemoglobinopathy.
    • Peripheral vascular disease affects pulse oximetry signal quality.
    • More than two attempts at lumbar puncture or failed.
    • Inadequate spinal block.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Modèles d'observation: COHORT
  • Perspectives temporelles: PROSPECTIVE

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Perfusion Index (PI) group measured by pulse oximeter
  • Perfusion Index (PI) is measured using a validated multi-parameter monitor with a pulse oximetry module (Mindray uMEC 12 or equivalent).
  • The probe is placed on the right index finger in the supine position before induction of spinal anesthesia block.
  • Three consecutive readings are recorded at 1-minute intervals.
  • These steps will be repeated with another reading after delivery of baby.
  • Then the mean value is used as the baseline PI.
  • The cut-off applied is: -
  • 3.5 or less (low risk for hypotension)
  • Greater than 3.5 (high risk for hypotension)

is measured using a validated multi-parameter monitor with a pulse oximetry module (Mindray uMEC 12 or equivalent).

  • The probe is placed on the right index finger in the supine position before induction of spinal anesthesia block.
  • Three consecutive readings are recorded at 1-minute intervals.
  • These steps will be repeated with another reading after delivery of baby.
  • Then the mean value is used as the baseline PI.
  • The cut-off applied is: -
  • 3.5 or less (low risk for hypotension)
  • Greater than 3.5 (high risk for hypotension)
Internal Jugular Vein Collapsibility Index group will be measured by ultrasonography
  • Internal Jugular Vein Collapsibility Index will be measured by Ultrasonographic assessment and is performed by using a 6-10 MHz linear ultrasound probe.
  • The patient is placed supine with 15 degree left lateral tilt.
  • The probe is positioned horizontally at the right side of the neck at the level of the middle thyroid cartilage, obtaining a transverse view of the right IJV. M-mode imaging during both spontaneous and deep breathing.
  • Anteroposterior diameters of the IJV were estimated during the respiratory cycle. The IJV collapsibility index (IJVCI) was estimated via the following equation: Maximum diameter - lowest diameter/maximum diameter) 100% [20].
  • The mean of three consecutive measurements is recorded for each breathing mode in quite respiratory cycle .
  • Images will be saved for offline analysis.
  • The cut-off applied is:

IJVCI < 35-38% → lower risk of post-spinal hypotension IJVCI ≥ 38-40% → higher likelihood of hypotension after

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Délai
compare the diagnostic accuracy assessed by ROC curve analysis between Perfusion Index (PI) & Internal Jugular Vein Collapsibility Index (IJVCI) combined with Cardiac Index (CI) in predicting post-spinal hypotension in elective CS patients.
Délai: • Three consecutive readings are recorded at 1-minute intervals. • These steps will be repeated with another reading after delivery of baby.
• Three consecutive readings are recorded at 1-minute intervals. • These steps will be repeated with another reading after delivery of baby.

Mesures de résultats secondaires

Mesure des résultats
Délai
measure systolic arterial blood pressure changes after spinal anesthesia.
Délai: immediately after spinal anesthesia
immediately after spinal anesthesia
Total ephedrine dose or phenylephrine dose /milligram.
Délai: throughout the operation
throughout the operation

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 décembre 2026

Achèvement primaire (Estimé)

1 décembre 2027

Achèvement de l'étude (Estimé)

1 décembre 2027

Dates d'inscription aux études

Première soumission

12 novembre 2026

Première soumission répondant aux critères de contrôle qualité

12 novembre 2026

Première publication (Réel)

19 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

19 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

12 novembre 2026

Dernière vérification

1 septembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 9/2026 ANET 53

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner